Chair of Molecular Microbiology
School of Biological Sciences
Royal Holloway University of London email@example.com
Dr Hong A. Huynh
CDVAX is a project funded under the European Union 7th Framework. The aim of CDVAX is to take forward a novel and highly innovative vaccine that could provide protection to Clostridium difficile infection. The project will evaluate vaccines in a human clinical trial.
To learn more about Clostridium difficile and the illness it causes click here.